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Systematic studies have shown that major depression, anxiety
states and adjustment disorders affect a significant proportion of
cancer patients to a degree that warrants intervention (Pinder et al,
1993; Aapro and Cull, 1999). These problems often go undetected
and untreated in routine oncology practice (Maguire, 1985; Cull
et al, 1995; Berard et al, 1998; Newell et al, 1998; Fallowfield
et al, 2001). Psychological comorbidity is associated with an
increased symptom burden, greater disability, poorer quality of
life, reduced compliance with medical treatment and a poorer
medical outcome for patient (Ramirez and House, 1997). It also
constitutes an increased burden for their carers. There is now
ample evidence of the efficacy of a range of psychological inter-
ventions (Meyer and Mark, 1995) in relieving cancer patients’
distress. In most health care systems the resources to provide these
interventions are limited and need to be targeted appropriately. 
Training in communication and counselling skills has been
increasingly available to oncology staff in recent years (Maguire
et al, 1996; Fallowfield et al, 1998). This should improve early
recognition of, and appropriate response to, patients’ concerns and
difficulties and may prevent problems from escalating. Even so, an
initial screening strategy based on patient self-report questionnaire
data may help staff in busy clinics to concentrate their efforts on
those most in need and to develop a rational basis for referral of
patients for specialist intervention. The administrative burden of
administering and scoring questionnaires hampers screening in
routine oncology practice. Electronic methods of data capture
offer the means of developing a practical and efficient screening
strategy for routine use. 
Comparing questionnaire administration by computer touch-
screen with paper forms subsequently scanned by an optical
reading system, we found the touchscreen system was well accept-
ed by oncology in-patients, quicker to use and provided better-
quality data. Agreement of scores between electronic and paper
forms and the test–retest reliability of the touchscreen data was
generally good (Velikova et al, 1999). In the present study the
automated system was applied in the outpatient setting to identify
patients whose questionnaire scores suggested clinically signifi-
cant levels of distress which would warrant further assessment in
the clinic. 
The optimal choice of screening tool(s) for this purpose remains
controversial. We were influenced in our selection of measures by
those already in use, e.g. for clinical trials, as well as the need for
economy in the total number of questions asked. The Hospital
Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983)
has been so widely used to assess psychological distress in cancer
patients in Europe that it appeared to be the first choice. However
the optimal choice of cut-off score for ‘case-identification’ is
controversial. Validation studies of the HADS against a standard
psychiatric interview in homogeneous samples of breast cancer
(Razavi et al, 1990; Hopwood et al, 1991a, b; Ramirez et al, 1995;
Hall et al, 1999) or lymphoma (Razavi et al, 1992) patients have
reported equivocal results about its screening performance. In a
heterogeneous sample Ibbotson et al (1994) recommended different
cut-off scores for optimal case identification for patients with
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different disease or treatment characteristics, i.e. disease-free,
stable or progressive disease; on or off treatment. In our study,
patients could not be asked to supply this information on their
arrival at clinic nor was it reliably accessible electronically from
patient records. We therefore sought alternative means of
improving the screening performance of the HADS. We consid-
ered that sequential HADS scores might provide more effective
screening in a setting where patients return regularly to the
oncology clinic. 
We also included possible alternatives or adjuncts to the HADS.
The 5-item Mental Health Inventory (Berwick et al, 1991), a
component of the SF-36 Health Survey (Ware, 1993), has been
validated as a screening tool against the Diagnostic Interview
Schedule. Potentially it offered a briefer alternative to the HADS.
In oncology clinics the EORTC QLQ-C30 (Aaronson et al, 1993)
has been shown to facilitate doctor–patient communication about
both physical and psychological functioning (Detmar and
Aaronson, 1998). It includes a 4-item emotional functioning (EF)
scale which has not yet been evaluated as a screening tool. The
nature and number of cancer patients’ concerns as assessed by a
brief checklist have been shown to be a useful marker for psychi-
atric morbidity (Harrison et al, 1994). The checklist provides a
helpful starting point for remedial intervention by identifying
concerns contributing to patients’ distress. The screening perfor-
mance of any of these measures could potentially be improved by
including information about known risk factors for psychological
morbidity, such as gender or past psychiatric history (Robertson
and Katona, 1997). The aim of this study was to assess the validity
of computer-administered screening questionnaires against a stan-
dard psychiatric interview for detecting clinically significant
levels of psychological distress in a mixed group of cancer patients
in routine oncology practice. Using the touchscreen system as the
screening platform, the specific objectives were: 
1. To determine the prevalence of clinically significant psych
logical morbidity as assessed by a standard clinical interview. 
2. To compare the screening performance of the individual
measures selected for use in this study. 
3. To assess whether the identification of ‘cases’ is improved by
using 2 sequential questionnaire assessments relative to data
from a single time point. 
4. To determine the optimal selection of measures (singly or in
combination) for ‘case’ identification in this setting. 
PATIENTS AND METHODS 
Patients 
Participants were day-patients attending for chemotherapy in 2
cancer centres in the UK. To be eligible for this study patients had
to be able to read English (to complete the questionnaires on the
touchscreen), to have 2 appointments at the hospital in a 6-week
period (after giving their consent) and to be available for interview
(at home or in hospital) within a week of the second questionnaire
assessment. 
Instruments 
HADS (Zigmond and Snaith, 1983). This instrument consists of
27-item subscales to measure anxiety and depression. Patients
respond by endorsing the response which best describes how they
have been feeling in the past week. Items are scored (0–3) and
summed to give subscale scores (0–21) for anxiety and depression,
and a total score (0–42). Higher scores denote greater distress. 
Mental Health Inventory – MHI-5 – UK version (Ware, 1993).
This consists of questions about anxiety (n = 1), depression (n =
1), loss of behavioural/emotional control (n = 1) and psychological
wellbeing (n = 2). Patients respond in terms of how much of the
time in the past 4 weeks they have been feeling like this from 1 (all
the time) to 6 (none of the time). Berwick’s original scoring
method (1991) was used to adjust for the direction of the items. A
higher score on the summary scale score (range 5–30) indicates
more distress. 
EORTC QLQ-C30, Emotional functioning scale – EF
(Aaronson et al, 1993). This 4-item scale contains items covering
tension, worry, irritability and depression experienced during the
past week. Responses are given on a 4-point scale from 1 (not at
all) to 4 (very much). The summary scale is linearly transformed to
a 0–100 scale where a higher score means better functioning. 
Concerns Checklist (Harrison et al, 1994). This 14-item check-
list refers to 13 cancer-related concerns (current illness, physical
symptoms, treatment, feeling different, feeling upset, inability to
do things, future, job, finances, relationship with partner, relation-
ship with others, sexuality, amount of support) and an open ‘other’
category. Patients rate how worrying they appraised each concern
to have been over ‘the last few weeks’ from 0 (not at all) to 4
(extremely). Ratings for each item were summed to give an aggre-
gate score (0–56). A higher score represents more worry. 
Past Psychiatric History – PH. Patients were asked to respond
yes/no to the following 2 questions (House, personal communica-
tion): Have you ever been treated for nervous or emotional prob-
lems such as anxiety or depression in the past at any time? – PH1;
Have you ever had an admission to hospital for nervous problems?
– PH2. 
Present State Examination – PSE (Wing et al, 1974). A short
form of this well validated and widely used psychiatric interview
schedule was used to elicit and rate psychiatric symptoms experi-
enced over the preceding month. Ratings were analysed using the
Catego computer program to detect ‘cases’ from the Index of
Definition (ID). This comprises a number of levels of certainty
that a psychiatric disorder is present from no symptoms at all
(ID1) through threshold disorders (ID5) to definite cases (ID6–8).
An individual who rates ID ≥ 5 can be given a diagnosis using
ICD-10 with the addition of a few extra questions to the PSE inter-
view. These questions, which do not affect the ID ratings, were
included in our interviews but are not separately reported here. 
Procedure 
Eligible patients were given written information and invited to
take part in the study by one of the research team in each centre
(VS, PW). Diagnostic and treatment data were extracted from the
patients’ casenotes. Patients were asked to give the following
sociodemographic information: age, sex, marital status, living
arrangements and postcode. The Social Deprivation Index (SDI)
was derived by translating patients’ postcodes into Carstairs scores
(Carstairs and Morris, 1991) which were expressed as quintiles
from 1 = most affluent to 5 = most socially deprived. General prac-
titioners were informed of their patients’ participation in the study.
Patients were shown how to use the touchscreen monitor and
asked to complete the computer-administered questionnaires on 2
separate clinic visits, a minimum of 2 and a maximum of 4 weeks1844 A Cull et al 
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apart. Patients were interviewed by an interviewer trained in the
use of the PSE (VS, PW), either at the clinic after the second ques-
tionnaire assessment or in their own homes in the ensuing week.
The interviewers, who were blind to the touchscreen scores, scored
patients’ responses on the standard interview rating schedule.
These data were entered into the Catego computer program. All
interviews were recorded on audiotape (subject to the patient
giving written informed consent). At the end of the study inter-
viewers re-rated audiotapes of a randomly selected 10% of their
own interviews (without reference to their original ratings).
Interviewers’ re-ratings were concordant with their original ratings
on 96% of the interviews sampled. A further 10% of interviews
were exchanged between the interviewers who rated the audio-
tapes blind to the original ratings. Inter-rater reliability was satis-
factory with 88% concordance in case identification between the 2
interviewers. An experienced PSE trainer (AH) independently
rated the interviews in question and discrepancies were resolved
by consensus. 
Statistical methods 
The statistical analysis was carried out using the S-PLUS system
(1997). For comparison of proportions the χ 2 test was used
(Armitage, 1971). Logistic regression (McCullagh and Nelder,
1989) was used to build models to predict ‘caseness’. A cross-
validated variable selection (Harrell et al, 1998, 2000) was used to
find the most predictive of the variables and to provide robust esti-
mates of the R2 statistic. These ‘corrected’ values of R2 provide a
less over-optimistic prediction of the performance of the model
when applied to data which were not used to build it. Receiver
operating characteristic (ROC) curves (Murphy et al, 1987) were
used to represent the ability of the measures to discriminate
between ‘cases’ and ‘not cases’. The area under the ROC curve, or
AUC provides a summary measure of the performance of a
screening decision rule across the range of possible cut-off points.
The higher the AUC, the better the predictive ability of the rule.
The cross-validated variable selection method referred to above
also provided robust estimates of the areas under the ROC curves.
These estimates are referred to as ‘corrected’ in the text. The
screening performance of the selected instruments was assessed by
reference to their sensitivity and specificity. Sensitivity refers to
the proportion of correctly identified ‘cases’ (true case/true posi-
tives + false negatives). Specificity refers to the proportion of
correctly identified non-cases (true negatives/true negatives +
false positives). Hence the false positive rate is 1 – specificity. The
positive predictive value (PPV) was calculated to give the proba-
bility of being a ‘case’ at a given cut-off point (true positives/true
positives + false positives). The misclassification rate (MR) refers
to the number of patients misclassified (false negatives + false
positives/ total no. of patients) by the screening instrument in
question. A decision tree was used to confirm the optimal
screening strategy (Venables and Riplay, 1997). Cross-validation
methods were also applied to avoid over-fitting of the data. 
RESULTS 
Of 298 patients approached 40 (13%) refused to take part in the
study and 15 (5%) withdrew after the first assessment (response
rate 82%). A further 36 (12%) patients had subsequently to be
excluded from the analysis for clinical reasons when a change in
their health status or treatment plan meant that the assessments
could not be completed in the time-frame required by our protocol.
Of 207 patients who underwent the PSE interview, 35 patients
were withdrawn from the analysis after technical problems
resulted in the loss of one or both sets of questionnaire data. A
complete dataset, of 2 sets of questionnaire data from touchscreen
administration (collected 2–4 weeks apart) and a PSE interview,
was available for 172 patients in the 2 centres. 
The sample consisted of 66 (38%) men and 106 (62%) women
in the age range 21–81 years (median = 57). The majority were
married (69%); 16% lived alone. The SDI showed the following
distribution: 1 (most affluent) = 24%; 2 = 19%; 3 = 19%; 4 = 20%;
5 (most deprived) = 14%. Postcodes were unknown for 4% of the
sample. The majority (99%) of patients were white. Patients with
colorectal (n = 49), breast (n = 37) or ovarian (n = 34) cancer or
lymphoma (n = 19) accounted for 81% of the sample. The
remaining 33 patients were heterogeneous with respect to their
cancer diagnosis. Responses to the questions about psychiatric
history showed that 22% of the sample had had some history of
treatment for ‘nervous or emotional problems’ in the past (PH1)
and for 4% this had warranted hospital treatment (PH2). 
1. Prevalence of clinically significant psychiatric morbidity 
From 172 PSE interviews 16 patients (9%) were identified as
‘definite cases’ (Catego ID scores 6–8) and a further 24 (14%) as
‘threshold disorders’ (Catego ID score = 5), i.e. a total of 40 (23%)
patients whose level of distress warranted some clinical interven-
tion. In the analyses which follow patients with Catego ID scores
≥ 5 are designated ‘cases’. The Catego ID scores of the 35 patients
who had had to be excluded from the main study analysis because
of incomplete touchscreen data were not significantly different
from the Catego scores of these patients with full data (χ 2 = 3.78,
df = 6, P = 0.71). Table 1 shows (a) the distribution of sociodemo-
graphic and past psychiatric history characteristics in the sample,
(b) the percentage of patients with each of these characteristics
who were identified as ‘cases’ and (c) the distribution of these
characteristics among the 40 patients identified as ‘cases’. The
only variable showing a significant association with Catego ‘case-
ness’ on univariate analysis was past psychiatric history (PH1).
Patients who had previously been treated for nervous or emotional
problems were twice as likely to be identified as ‘cases’ on clinical
interview as patients with no such history (38% vs 19%; χ 2 = 5.62,
df = 1, P = 0.02). 
The following variables were entered into a logistic regression
analysis to predict ‘caseness’: sex, age, marital status, living status,
SDI and the responses to the 2 questions about past psychiatric
history (PH1, PH2). Age and SDI were treated as continuous vari-
ables in the regression analysis. Cancer diagnosis was not included
in the model. Younger age (odds ratio 0.96, (95% confidence
interval: 0.93–0.99) for each successive year of age) and past
psychiatric history, as defined by an affirmative response to PH1,
(odds ratio 2.47, 95% CI: 1.00–6.11) were significant in the
prediction of ‘caseness’. 
2. Comparison of the performance of the screening
questionnaires used in the study 
There were no significant differences between scores at the first
and second administration for any of the measures used. Data from
the second administration i.e. temporally closest to the interview,
were examined first. The median scores (and ranges) from the
second assessment were as follows: HADS 9.0 (0–31); MHI5 10.0
(5–22); EORTC QLQ-C30 75.0 (16.7–100); Concerns 8.0 (0–34).Automated screening for psychological distress 1845
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Scores on the 4 questionnaire measures were highly inter-
correlated with each other (Table 2) and in each case showed a
significant (P < 0.001) linear relationship with Catego ID scores. 
Logistic regression was used to assess the performance of the 4
individual questionnaires in predicting ‘caseness’. Each question-
naire was tested separately in a model with the same sociodemo-
graphic and psychiatric history variables as before. None of the
sociodemographic or psychiatric history variables was significant
in a model where scores from at least one of the questionnaires
were included. Taken singly, each of the questionnaires was signif-
icant (P < 0.001) in these models. HADS and MHI-5 scores were
the best single predictors of ‘caseness’ as judged by the highest R2
and area under the ROC curve (AUC). 
3. Comparing data from 2 sequential assessments with
data from a single time point 
A logistic regression model was built to predict ‘caseness’ using the
sociodemographic data as before and all the scores from the second
assessment (Model 1). Then questionnaire data from the first assess-
ment were added (Model 2). The models were compared. Model 2
fits the data significantly better than Model 1 (χ 2 = 10.4, df = 4, P =
0.03) indicating that the inclusion of the questionnaire data from 2
time points did improve the prediction of ‘caseness’ when all the
measures used were included in the analysis. 
4. The optimal selection of measures (singly or in
combination) for case-identification 
The most parsimonious sub-models of Models 1 and 2 were found
using cross-validated stepwise elimination of the variables. The
reduced models, Model 1a and 2a respectively, are specified in the
footnote of Table 3. Both of these models fit the data as well as the
full models and the corrected R2 and AUC statistics are improved.
This reflects the probable overfitting in the ‘full’ models 1 and 2.
Models 1a and 2a are very similar in terms of their corrected R2
and AUC. In both cases only the HADS and MHI5 are included.
Models were generated using all other possible combinations of
HADS and MHI5 scores. Combining data from two administra-
tions of the HADS was significantly better than predicting ‘case-
ness’ from a single HADS (χ 2 = 4.04, df = 1, P = 0.04). Of all the
Table 1 Sociodemographic and clinical characteristics by ‘caseness’ on PSE interview 
Variable No. of  % of patients with this  % of ‘cases’ 
patients characteristic who have  i.e. Catego ID score ≥ 5 
Catego ID score ≥ 5 who have this characteristic 
(i.e. of n = 40) 
Gender
men 66 17 28
women 106 27 72 
Age
< 50 50 30 38 
≥ 50 122 21 62 
Marital status
single 20 25 13 
married 119 22 65 
separated/widowed/divorced 33 27 22 
Living status
alone 28 18 13 
with others 144 24 87 
SDIa
1/2 74 23 43 
3 32 22 17 
4/5 59 24 35 
Diagnosis
breast 37 22 20 
ovarian 34 32 28 
colorectal 49 18 22 
lymphoma 19 11 5 
other 33 30 25 
Past psych history (PH1)
Yes 37 38 35 
No 135 19 65 
Past psych admission (PH2)
Yes 7 29 5
No 165 23 95 
a7 patients had no SDI recorded; 2 of them were cases. 
Table 2 Correlation between questionnaire scores (2nd assessment) and,
for each questionnaire, with Catego scores (Pearson’s r) 
HADS.2 MH15.2 EF.2 Concerns.2 
HADS.2 – 0.77 – 0.71 0.74 
MH1–5.2 –– – 0.61 0.63 
EF.2 –– – – 0.63 
Concerns.2 –– ––  
Catego 0.57 0.55 – 0.45 0.49 1846 A Cull et al 
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regression models generated, Model 2a fitted the data best by
every criterion although the differences between the models were
not statistically significant. 
The performance of the screening strategies implied by these
analyses was compared (Table 3). The screening performance of
HADS was assessed with respect to cut-offs cited in the literature
(Razavi et al, 1990; Ibbotson et al, 1994). For ease of comparison in
Table 3 the screening performance of MHI5 and the 2 best regres-
sion models (1a and 2a) are described for sensitivity values of 85%
and 70%. For HADS.2 to achieve a sensitivity of 85% the cutoff
score had to be reduced to 7, resulting in a specificity of only 48%. 
Linear regression models do not readily allow for stepwise splits
in screening scores which can be accommodated in decision tree
analysis. Cross-validated decision trees were constructed with the
choice of variables informed by the logistic regression analyses
above. A decision tree is a representation of successive splits of the
patients into 2 sets according to values of the predictor variables.
Here the sets are chosen to maximize the difference in the propor-
tion of patients classified as ‘cases’ between the two sets. The
procedure examines every possible split of every predictor variable
and chooses the optimal split at each stage. Having held a (random)
proportion of patients from the original analysis, the tree is then
cross-validated by testing the performance of the resulting classifi-
cation rule on these excluded patients. This cross-validation proce-
dure avoids over-splitting the dataset, which would result in an
overoptimistic decision rule. The decision tree represents a parti-
tion of patients into subsets who are more, and less, likely to be
classified as ‘cases’. For each tree each ‘terminal node’ contains a
proportion of ‘cases’. The threshold proportion for classifying a
node as ‘case’ can be varied, resulting in variable values for sensi-
tivity and specificity. This produces a ROC curve for the tree. 
The best cross-validated tree informed by Model 2a is shown in
Figure 1. As shown the proportions of cases in successive shaded
nodes take the values 0, 0.118, 0.329 and 0.812. 
If all nodes with proportion of cases > 0.25 are classified as
cases a sensitivity of 90% is achieved with 62% specificity. The
PPV is then 42% and the MR = 31%. The decision rules for
screening which emerge from this analysis are thus: 
(a) HADS score ≥ 20 = ‘case’ 
HADS score < 9 = ‘not case’ 
(b) HADS score ≥ 9, < 20 then administer MHI5 
If MHI5 score ≥ 9 = ‘case’; MHI5 score < 9 = ‘not case’ 
The decision tree analysis for Model 1a highlighted an anomaly in
the HADS.2 data: among 19 patients with a score of 12, 13 or 14
there was only 1 ‘case’ as compared with 15 ‘cases’ among the
63 patients scoring ≤ 11. This results in anomalies in the decision
tree but does not invalidate the logistic regression model. The
latter forces a monotonic relationship which smoothes out irregu-
larities in the data. Data from the first administration of HADS
and MHI5 were therefore also explored. Figure 2 shows the best
Table 3 Comparison of the performance of screening strategies: using HADS and MH15 singly and in optimal combination (Models 1a and
2a and decision trees) 
Cutpointa Sensitivity Specificity Positive  Misclassification 
(%) (%) predictive rate 
value (%) (%) 
HADS1 13 60 83 52 22 
15 48 89 57 21 
19 33 98 83 17 
MH15.1 10 85 52 35 40 
11 70 63 36 35 
HADS2 13 60 85 55 21 
15 50 91 63 19 
19 25 99 88 18 
MH15.2 9 85 54 36 39 
11 70 72 43 28 
Model 1ab – 1.9 85 58 38 36 
– 1.2 70 75 46 26 
Model 2ac – 2.0 85 58 38 36 
– 1.2 70 75 46 26 
Decision tree using HADS1 and MH15.1 See Figure 2 85 71 47 26 
Decision tree applied to HADS2, MHI5.2 As per Figure 2 73 70 43 29 
aClassify as case if scoring higher than this value. bModel 1a: score = –5.06 + 0.13*HADS.2 + 0.20*MH15.2. 
cModel 2a: score = –5.64 + 0.13*HADS1 + 0.24*MH15.2. 
  40/172 
27/156 
27/104 
23/70 = 0.329  4/34 = 0.118 
 0/52 = 0 
13/16 = 0.812  
HADS1 < 20   HADS1 > = 20  
MHI5.2 < 9   MHI5.2 > = 9  
HADS1 < 9   HADS1 > = 9  
Terminal node designated  case  denoted by heavy outline
Figure 1 Decision tree analysis for case-identification using HADS.1 and
MH15.2 (Model 2a) Automated screening for psychological distress 1847
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cross-validated tree in which the first node splits patients by MHI5
scores < 11 vs ≥ 11. In the former set, 6 of 75 patients are ‘cases’
(8%) and this set does not warrant further splits. In the latter set, 34
of 97 patients are ‘cases’ (35%). In this set a further split based on
HADS scores < 9 vs ≥ 9 further improves the classification of
‘cases’: among those scoring HADS < 9 there are no ‘cases’ while
among those with MHI5 ≥ 11 and HADS ≥ 9 the proportion of cases
is now 47% (34 out of 72 patients). If all nodes with proportion of
cases > 0.45 are classified as cases (i.e. only the node on the far
right of the figure), the decision tree achieves sensitivity of 85%
(34/40), specificity of 71% (94/132) and a MR of 26% (6 + 38/172).
The PPV is 47%. The decision rules for screening based on this
analysis are: 
(a) MHI5 score < 11 = ‘not case’ 
(b) MHI5 score ≥ 11 administer HADS 
(c) If HADS score < 9 = ‘not case’; HADS score ≥ 9 = ‘case’. 
To test the robustness of this decision tree model these rules were
applied to the data derived from HADS and MHI5 at the second
assessment. The screening strategy showed a sensitivity of 73%
and a specificity of 70% with a misclassification rate of 29% and a
positive predictive value of 43%. For ease of comparison the
screening properties of the trees are also shown in Table 3. 
DISCUSSION 
The aim of our research programme is to develop and test an auto-
mated system for collecting and using patient self-report data in
clinical practice. The study reported here was a first attempt to
harness the potential benefits of the system to the important
problem of detecting patients with clinically significant levels of
distress. 
We selected patients undergoing chemotherapy for our sample
for this study. Since they return to hospital on a regular basis they
offered us optimal conditions for testing our hypothesis about the
value of sequential screening assessments. Specifically we could
obtain 2 screening assessments referring to approximately the
same time span of the patient’s experience as the ‘gold standard’
interview. We reasoned that if sequential assessment did not
improve screening performance in this study it would be unlikely
to do so in other areas of oncology practice where the frequency of
patient contact is more varied. Within our ongoing programme of
work this study was designed to explore the validity of touch-
screen data for screening purposes. It was recognized that any
screening algorithm developed from this study would require to be
validated in an independent sample and that its generalizability
would require to be tested in other clinical settings. 
The results of computerized screening are encouraging.
Patients’ scores on questionnaires administered by touchscreen
correlated highly with the Catego ID scores derived from their
PSE interviews and were predictive of ‘caseness’. This supports
the validity of using the automated system for collecting patient
self-report data about psychological distress. Including sociode-
mographic data and information about past psychiatric history did
not improve the screening performance of the measures selected.
Combining data from sequential timepoints did improve the
screening performance of the HADS and of the whole assessment
battery. However the best screening strategy was derived by
combining scores from 2 instruments – MHI5 and HADS, from a
single time point. Several issues which limit the interpretation of
these findings warrant further discussion. 
On a ‘gold standard’ clinical interview 9% of patients were
identified as showing ‘case level’ symptomatology and a further
14% were ‘threshold cases’. It is likely that our sample is biased
towards the inclusion of patients who were fitter, physically and/or
emotionally. When patients specified reasons for refusal to partici-
pate in the study (n = 24/40) the most commonly cited were: ‘too
distressed’ (n = 8); ‘can’t be bothered’ (n = 6) and ‘feel too ill’ 
(n = 5). Our previous study (Velikova et al, 1999) found in-
patients’ refusal to participate related to disease severity. In our
on-going work in outpatient clinics (unpublished data), with-
drawing from repeated screening is predicted by higher HADS
scores at earlier assessment. In the present study data were
excluded when patients could not complete the assessments in the
time-frame required, i.e. chemotherapy was delayed or discon-
tinued. This usually reflected deterioration in the patient’s health.
This may well have been associated with distress which we did not
capture in this study. For all these reasons it is likely we have
reported an underestimate of the prevalence of clinically signifi-
cant distress in this patient population. Non-compliance with
touchscreen assessment in the outpatient setting may in itself be a
useful cue to staff to make a clinical assessment of the patients’
emotional status. We are evaluating this in our on-going work. 
The loss of data for technical reasons was disappointing. There
are several possible explanations including: patient error in data
entry; error in downloading the data from the touchscreen software
to the database within the computer used for data collection; or,
error in the subsequent downloading to the computer used for data
analysis. It seems unlikely the data were lost by patient error. In
most cases the data were lost from only one of 2 assessments and
not necessarily the first occasion the patient used the system.
Errors in downloading data at the end of clinics would have been
expected to affect whole tranches of data rather than the random
pattern of loss which we observed. Interview data from patients
whose touchscreen data were lost confirms this loss was not a
source of systematic bias. 
When we became aware of loss of data a number of measures
were introduced. Some of the computers used for data-collection
were encased to preclude access to the keyboard or barcoders
except by members of the team. Data loss was reduced to less than
1% in these computers. The development of this field is not
limited by the hardware. New systems, including portable tablet
computers and customized computers for touchscreen data collec-
tion are now readily available. We have now adopted a rigorous
approach to incorporating new hardware and to security issues,
which we believe to be essential in this field. The software has
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been upgraded to make data entry and download more robust.
Training procedures for staff operating the computers in the clinic
have been formalized. The problem of data loss has not recurred in
our ongoing studies. This reassures us that hardware, software and
training solutions are readily available to take forward the reliable
use of touchscreens to assist clinic staff in collecting patient self-
report data in routine oncology practice. 
The patients included in this study were heterogeneous with
respect to diagnosis and disease stage, but all were receiving
outpatient chemotherapy. Further work is required to validate the
use of this screening system among patients with different clinical
characteristics. At the time of this study we were not able to derive
data electronically from patients records for use in the screening
process and could incorporate in the screening algorithm only
information which patients could give on arrival at clinic, i.e.
sociodemographic details and questionnaire responses, not clinical
information. We considered variables known to be associated with
increased incidence of psychological morbidity. Age and past
psychiatric history were significant predictors of ‘caseness’,
surprisingly, gender was not. When questionnaire scores were
included in the predictive model there was no evidence that any of
these variables contributed to the screening performance of the
instruments used in this study. 
Patients’ questionnaire scores on screening were not significantly
different across the 2 assessments. The measures used were signifi-
cantly correlated with each other and individually, with Catego
ID scores. Taken singly, each was a highly significant predictor of
‘caseness’. The MHI5 and HADS were the best single predictors
of ‘caseness’. As these were designed as screening measures this is
not surprising. Its short time-frame relative to that used in standard
psychiatric interviews, may compromise the screening performance
of the HADS. Our results confirmed that using sequential HADS
scores did significantly improve screening performance over a
single HADS. Including all questionnaire data from sequential
assessments, 2–4 weeks apart, improved the regression model. 
This preliminary study did not have the power to detect statisti-
cally significant differences between all the possible alternative
models for combining data from the 2 assessments. Comparison of
regression models suggested an advantage to combining scores
from MHI5 and HADS to predict ‘caseness’. Replication in a
much larger sample would be needed to confirm the optimal use of
these instruments. The screening performance of the best regres-
sion model (i.e. Model 2a, HADS.1 + MHI5.2) was disappointing
(Table 3). We therefore considered a non-linear solution. Decision
tree analysis allows stepwise splits in the screening scores. The
screening rules derived from this analysis (Figure 1) allowed
Catego ‘cases’ to be identified with a high level of sensitivity
(90%) but at a cost of a rather low specificity (62%). This model
was illogical clinically, presenting the longer instrument before the
shorter and potentially better predictor. We therefore explored
other solutions. The decision-tree method was also applied to
Model 1a (HADS.2 + MHI5.2). With some splits in the data a
higher proportion of ‘cases’ was revealed among patients with
lower vs higher HADS scores. These chance findings did not
invalidate the linear regression analysis but decision analysis
based on those thresholds would be clinically meaningless.
Technically the best screening strategy, identified by the tree
method (Figure 2 – MHI5.1 + HADS.1), is satisfying both for its
clinical logic and screening performance. The data used are
derived from a single assessment and screening begins with the
shorter instrument – MHI5. Only patients who score > 11 need be
asked to complete the HADS. This strategy correctly identified
85% of Catego ‘cases’. Of the 6 ‘cases’ misclassified as ‘not
cases’, two thirds had a Catego score of 5, i.e. ‘threshold disorder’.
The specificity and positive predictive value of this strategy were
somewhat better than for the tree based on Model 2a, implying
greater efficiency in the use of staff time to assess screen-positive
patients. Replication in another sample of patients drawn from the
same population would be required before this preferred screening
strategy could be recommended. 
In busy clinical practice it is important to weigh the benefits of
maximizing  ‘case-identification’ against the cost of flagging a
high number of ‘non-cases’ to staff as requiring fuller assessment.
In our study a moderate false-negative rate was acceptable because
patients were returning to hospital and interacting with health
professionals on a regular basis, giving other opportunities for
‘cases’ missed on screening to be picked up subsequently. It is
important to stress that however effective the screening system
eventually developed, it is intended as an aid to, and not a substi-
tute for, doctor–patient communication. We have also suggested
that patients’ non-participation in screening may be informative as
a cue to clinical assessment. 
There is clearly scope for using the touchscreen system to
explore the screening performance of other combinations of items
and scales. Recently the GHQ-12 has been recommended as an
alternative to the HADS (Hall et al, 1999) in oncology clinics.
Single items such as – ‘Are you depressed?’ – which has been
found reliable and valid as a screening tool among terminally ill
patients (Chochinov et al, 1997), also warrant further considera-
tion here. Most diagnostic interviews have a structure in which
response to an opening question determines whether more detailed
enquiry about psychological symptoms is pursued. A similar
branching approach in computerized screening may be useful and
should be further explored. 
Health-related quality of life (QL) assessment for the future is
moving towards computer-adaptive testing (Revicki and Cella,
1997) based on the application of item response theory (IRT) to
characterize whole banks of questionnaire items for a number of
QL dimensions. This approach, first used in educational assess-
ment, holds the promise of enabling the generation of brief and
more precise assessments of psychological morbidity tailored to
the individual patient. Data collection by touchscreen computer in
routine oncology practice offers the opportunity to improve the
identification of patients with clinically significant levels of
distress. A recent systematic review (Gilbody et al, 2001) exam-
ining evidence of the effect of routine screening on the recogni-
tion, management and outcome of psychiatric disorders in
non-psychiatric settings, confirmed the value of providing clini-
cians with feedback only about those who screen positive.
Computer-administered screening is a promising platform from
which to develop a rational strategy for offering a range of
psychosocial interventions appropriately to patients most in need
of them. Further work is needed to develop the optimal selection of
screening questions for this purpose. 
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